drugset / Trial / NCT00677469

Low Doses of Cholestyramine in the Treatment of Hyperthyroidism

NCT00677469

RandomizedParallel-groupTriple-blindTreatment

Summary

The enterohepatic circulation of thyroid hormones is increased in thyrotoxicosis.Bile-salt sequestrants (ionic exchange resins) bind thyroid hormones in the intestine and thereby increase their fecal excretion. Based on these observations, the use of cholestyramine has been tried. The present study evaluates the effect of low doses of cholestyramine as an adjunctive therapy in the management of hyperthyroidism

Timeline

Start
2007-07
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholestyramine Other / unclassified 1 g Oral
Subject Cholestyramine Other / unclassified 2 g Oral

Indications